Table 2. Clinical data of healthy subjects and coronary artery disease patients.
Characteristic | Healthy controls | Coronary artery disease patients | p-value |
Age, years | 33.86±6.32 | 68.47±14.15 | <0.001 |
Gender (female/male) | 11/3 | 6/13 | 0.013 |
BMI | 22.42±1.65 | 25.53±3.37 | 0.003 |
TC concentration, mmol/l | 4.00±0.57 | 4.32±0.84 | 0.222 |
HDL concentration,mmol/l | 1.34±0.95 | 1.23±0.24 | 0.082 |
LDL concentration,mmol/l | 2.18±0.53 | 2.83±1.09 | 0.031 |
TG concentration,mmol/l | 1.50±0.48 | 2.11±1.33 | 0.078 |
DM | 0(10) | 4(19) | 0.119 |
Medication | |||
Platelet inhibitor | 0(10) | 10(19) | - |
Beta-blocker | 0(10) | 3(19) | - |
ACE-I/ARB | 0(10) | 2(19) | - |
Calcium channel blockers | 0(10) | 5(19) | - |
Values are expressed as the mean ±SD or as the number of subjects. BMI: body mass index; DM: diabetes mellitus; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglyceride; ACE-I/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker. A value of P<0.05 was considered significant difference.